Clinical Trial Update: Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating a single 125 mg subcutaneous dose of abatacept delivered by BD Autoinjector or prefilled syringe in rheumatoid arthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Orencia (abatacept) (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2015-11-26